Omzet 2024 * | 22,15 mln. 27,69 mln. 25,93 mln. | Omzet 2025 * | 36,37 mln. 45,46 mln. 42,57 mln. | Marktkapitalisatie | 813 mln. 1,02 mld. 951 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -42 mln. -52,5 mln. -49,17 mln. | Nettowinst (verlies) 2025 * | -72 mln. -90 mln. -84,29 mln. | EV/omzet 2024 * | 32,6 x |
Nettoliquiditeiten 2024 * | 91,29 mln. 114 mln. 107 mln. | Nettoliquiditeiten 2025 * | 82,95 mln. 104 mln. 97,11 mln. | EV/omzet 2025 * | 20,1 x |
K/w-verhouding 2024 * |
-46,8
x | K/w-verhouding 2025 * |
-33,6
x | Werknemers | 109 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 0% |
Recentste transcriptie over Silence Therapeutics plc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Craig Tooman
CEO | Chief Executive Officer | 58 | 06-01-21 |
Director of Finance/CFO | 52 | 01-04-21 | |
Curtis Rambaran
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Steven Romano
CTO | Chief Tech/Sci/R&D Officer | 64 | 29-07-19 |
David Lemus
BRD | Director/Board Member | 61 | 21-06-18 |
Iain Ross
CHM | Chairman | 71 | 02-07-04 |